Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lincoln, Nebraska 68502


Purpose:

The purpose of the study is to characterize the metabolism and excretion (ADME) of a single oral dose of [14C]varespladib methyl.


Criteria:

Inclusion Criteria: - Provision of signed, written and dated informed consent prior to any study specific procedure - Healthy males, 19 to 55 years of age - Have a body mass index (BMI) between 18 and 35 kg/m2 inclusive Exclusion Criteria: - History or presence of any clinically significant disease or disorder in the opinion of the investigator - Any clinically relevant abnormal findings in physical examination, clinical chemistry, haematology, urinalysis, or vital signs at baseline in the opinion of the investigator


NCT ID:

NCT01359605


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Lincoln, Nebraska 68502
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.